Health ministry notifies provisions under Drugs Rules to manufacture, stock, sale new drugs in wake of Covid-19

The outbreak of Covid-19 pandemic has made it necessary to regulate the manufacture, stock, sale or distribution of new drug for prevention and treatment of associated infections,” the union health ministry notification stated. Union health ministry has notified provisions under Drugs Rules, 1945 and New Drugs and Clinical Trials (NDCT) Rules, 2019, to manufacture, stock, … Read more